Clinical trial
Active-NBS Liege - Monitoring the Motor Development of Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified Through Newborn Screening
NCT07286565 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Liege as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Active-NBS Liege - Monitoring the Motor Development of Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified Through Newborn Screening
- Lead sponsor
- Centre Hospitalier Universitaire de Liege
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 1, 2025
- Completion date
- August 31, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
duchenne muscular dystrophy (dmd), spinal muscular atrophy (sma)